Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

por Urup, Thomas, Gillberg, Linn, Kaastrup, Katja, Lü, Maya Jeje Schuang, Michaelsen, Signe Regner, Andrée Larsen, Vibeke, Christensen, Ib Jarle, Broholm, Helle, Lassen, Ulrik, Grønbæk, Kirsten, Poulsen, Hans Skovgaard
Publicado 2020